SAN FRANCISCO - (Business Wire) Fluxion Biosciences announced today an exclusive distribution agreement with Basel-based Bucher Biotec AG. Bucher will handle sales and service in Switzerland of Fluxion
’s BioFlux
™ research tools for live cell image analysis in drug discovery.
Bucher Biotec AG is a privately held Swiss distributor company representing major U.S., European and Japanese manufacturers of scientific instruments and associated consumables for life science research.
“We selected Bucher as our distribution partner in Switzerland because of their track record and reputation among customers in cell biology,” explained Mark Atlas, director of sales for Fluxion. “Our product fits nicely into their portfolio and enables them to expand their breadth of offerings.”
“The cutting-edge BioFlux systems for live cell imaging will be of interest to our current customers and will help us attract new ones,” commented Roland Bucher, CEO of Bucher Biotec AG. “Our sales, scientific support and service team bring the highest pre- and post-sales customer support to the Fluxion products and its applications.”
The Fluxion BioFlux 200 system is ideal for live cell imaging in applications such as cell adhesion and microbial biofilm studies. BioFlux 200 incorporates Fluxion’s proprietary microfluidic design to deliver an automated, reproducible system for studying live cells and biofilms under controlled-shear conditions. The system simulates in vivo physiological conditions more closely and at higher throughput than other approaches.
About Fluxion Biosciences
Fluxion Biosciences provides cellular analysis tools for use in critical life science research and drug discovery applications. Fluxion’s proprietary microfluidic platform enables precise functional analysis of individual cells in a multiplexed format. Fluxion’s systems meet the rigorous demands of life science and drug discovery scientists by providing an intuitive, easy-to-use operating system for single-cell biology. For more information about Fluxion Biosciences, visit www.fluxionbio.com.
Dahlgren Communications
Jennifer Dahlgren, 530-265-0538
jdahlgren@gv.net
or
Fluxion Biosciences
Mark Atlas, 650-241-4740
mark.atlas@fluxionbio.com
